UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 15, 2005
SAFETEK INTERNATIONAL, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 33-22175 75-2226896
---------------------------- ------------ -------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
5509 11th Avenue
Brooklyn, NY 11219
----------------------------------------
(Address of principal executive offices)
718-383-5255
----------------------------------------------------
(Registrant's telephone number, including area code)
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Section 5 Corporate Governance and Management
Item 5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers.
On April 15, 2005, Mr. Shmuel Shneibalg, who had been serving as the director
and as the Chairman, Chief Executive Officer, and Secretary of Safetek
International, Inc. (the "Registrant"), resigned from all his positions as
director and officer of the Registrant.
On April 15, 2005, Mr. Shay Goldstein was appointed as the director and as the
Chairman, Chief Executive Officer, and Secretary of the Registrant. Mr.
Goldstein is not a director in any other reporting company. Mr. Goldstein has a
Doctor of Medicine degree from the Israel Institute of Technology and has
extensive experience in the development, financing, and marketing of businesses
involved in the life science and medical technology industries. Between April
2003 and January 2005, Mr. Goldstein was the manager of the marketing programs
of Rimed Ltd., an Israeli-based company that specializes in the development of
advanced neuro-diagnostic medical equipment. Between February 2004 and February
2005, Mr. Goldstein was a consultant to Silicom Ventures, a company that
provides financing to businesses involved in the life science and medical
technologies industries. Between June 2002 and September 2003, Mr. Goldstein was
the manager of the business development and marketing programs of Medidactic, an
Israeli-based company that provides marketing services to businesses involved in
the life science and medical technology industries. Between September 2001 and
June 2002, Mr. Goldstein was the manager of the business development and
marketing programs of Medidactic. Ltd, an Israeli-based company that provides
marketing and training services to businesses involved in the life science and
medical technology industries. Between December 2000 and August 2001, Mr.
Goldstein was the manager and a co-founder of Renaissance Biomedical Solutions,
an Israeli-based company involved in the development of a biochemical delivery
system for the treatment of neurodegenerative diseases. Between July 1999 and
December 2000, Mr. Goldstein was a doctor at the Israel National Institute of
Forensic Medicine.
Section 9-Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
(a) Financial Information. Not applicable
(b) Pro forma financial information. Not applicable
(c) Exhibits. Not applicable
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SAFETEK INTERNATIONAL, INC.
(Registrant)
By: /s/ Shay Goldstein
----------------------------------
Name: Shay Goldsten,
Title: Chairman, Chief Executive Officer,
Secretary, and Director
Date: April 19, 2005